Literature DB >> 22155827

Oseltamivir inhibits H7 influenza virus replication in mice inoculated by the ocular route.

Jessica A Belser1, Katrina Sleeman, Melissa B Pearce, Jacqueline M Katz, Larisa V Gubareva, Terrence M Tumpey.   

Abstract

The majority of human infections associated with H7 influenza viruses have resulted in ocular and not respiratory disease. While oseltamivir has been prescribed to individuals presenting with conjunctivitis following H7 virus exposure, it is unknown if oseltamivir inhibits virus replication in ocular tissue. We demonstrate that H7 viruses possess sensitivity to neuraminidase inhibitors and that administration of oseltamivir before ocular virus challenge in mice inhibits H7N7 and H7N3 virus replication in ocular and respiratory tissues.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22155827      PMCID: PMC3294944          DOI: 10.1128/AAC.06101-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

Review 1.  Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors.

Authors:  M Tisdale
Journal:  Rev Med Virol       Date:  2000 Jan-Feb       Impact factor: 6.989

2.  Phylogenetic analysis of H7 haemagglutinin subtype influenza A viruses.

Authors:  J Banks; E C Speidel; J W McCauley; D J Alexander
Journal:  Arch Virol       Date:  2000       Impact factor: 2.574

3.  Infection with highly pathogenic H7 influenza viruses results in an attenuated proinflammatory cytokine and chemokine response early after infection.

Authors:  Jessica A Belser; Hui Zeng; Jacqueline M Katz; Terrence M Tumpey
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

4.  4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro.

Authors:  J M Woods; R C Bethell; J A Coates; N Healy; S A Hiscox; B A Pearson; D M Ryan; J Ticehurst; J Tilling; S M Walcott
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

5.  Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus.

Authors:  Terrence M Tumpey; Adolfo García-Sastre; Andrea Mikulasova; Jeffery K Taubenberger; David E Swayne; Peter Palese; Christopher F Basler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-04       Impact factor: 11.205

6.  Inhibition of replication of avian influenza viruses by the neuraminidase inhibitor 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid.

Authors:  L V Gubareva; C R Penn; R G Webster
Journal:  Virology       Date:  1995-10-01       Impact factor: 3.616

7.  Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus.

Authors:  L V Gubareva; M N Matrosovich; M K Brenner; R C Bethell; R G Webster
Journal:  J Infect Dis       Date:  1998-11       Impact factor: 5.226

8.  Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome.

Authors:  Ron A M Fouchier; Peter M Schneeberger; Frans W Rozendaal; Jan M Broekman; Stiena A G Kemink; Vincent Munster; Thijs Kuiken; Guus F Rimmelzwaan; Martin Schutten; Gerard J J Van Doornum; Guus Koch; Arnold Bosman; Marion Koopmans; Albert D M E Osterhaus
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-26       Impact factor: 11.205

9.  Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands.

Authors:  Marion Koopmans; Berry Wilbrink; Marina Conyn; Gerard Natrop; Hans van der Nat; Harry Vennema; Adam Meijer; Jim van Steenbergen; Ron Fouchier; Albert Osterhaus; Arnold Bosman
Journal:  Lancet       Date:  2004-02-21       Impact factor: 79.321

10.  Human illness from avian influenza H7N3, British Columbia.

Authors:  S Aleina Tweed; Danuta M Skowronski; Samara T David; Andrew Larder; Martin Petric; Wayne Lees; Yan Li; Jacqueline Katz; Mel Krajden; Raymond Tellier; Christine Halpert; Martin Hirst; Caroline Astell; David Lawrence; Annie Mak
Journal:  Emerg Infect Dis       Date:  2004-12       Impact factor: 6.883

View more
  7 in total

1.  Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses.

Authors:  Hyeok-Il Kwon; Young-Il Kim; Su-Jin Park; Min-Suk Song; Eun-Ha Kim; Se Mi Kim; Young-Jae Si; In-Won Lee; Byung-Min Song; Youn-Jeong Lee; Seok Joong Yun; Wun-Jae Kim; Young Ki Choi
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

2.  Reduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice.

Authors:  Charlene Ranadheera; Mable W Hagan; Anders Leung; Brad Collignon; Todd Cutts; Steven Theriault; Carissa Embury-Hyatt; Darwyn Kobasa
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

Review 3.  Mammalian models for the study of H7 virus pathogenesis and transmission.

Authors:  Jessica A Belser; Terrence M Tumpey
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

Review 4.  Ocular tropism of respiratory viruses.

Authors:  Jessica A Belser; Paul A Rota; Terrence M Tumpey
Journal:  Microbiol Mol Biol Rev       Date:  2013-03       Impact factor: 11.056

5.  Role of H7 hemagglutinin in murine infectivity of influenza viruses following ocular inoculation.

Authors:  Jessica A Belser; Xiangjie Sun; Hannah M Creager; Adam Johnson; Callie Ridenour; Li-Mei Chen; Terrence M Tumpey; Taronna R Maines
Journal:  Virology       Date:  2016-12-10       Impact factor: 3.616

Review 6.  The eyes have it: influenza virus infection beyond the respiratory tract.

Authors:  Jessica A Belser; R Ryan Lash; Shikha Garg; Terrence M Tumpey; Taronna R Maines
Journal:  Lancet Infect Dis       Date:  2018-02-21       Impact factor: 25.071

Review 7.  The hidden burden of influenza: A review of the extra-pulmonary complications of influenza infection.

Authors:  Subhashini A Sellers; Robert S Hagan; Frederick G Hayden; William A Fischer
Journal:  Influenza Other Respir Viruses       Date:  2017-09       Impact factor: 4.380

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.